Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP948804.RAf7eYoSAJDs3xvF6Ld7AozMn6x7gI4YRTyXWhcO3OGlo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP948804.RAf7eYoSAJDs3xvF6Ld7AozMn6x7gI4YRTyXWhcO3OGlo130_assertion type Assertion NP948804.RAf7eYoSAJDs3xvF6Ld7AozMn6x7gI4YRTyXWhcO3OGlo130_head.
- NP948804.RAf7eYoSAJDs3xvF6Ld7AozMn6x7gI4YRTyXWhcO3OGlo130_assertion description "[The incidence of GVHD in matched and unmatched groups was respectively: grade I-IV: 81% and 86% (P = 0.492); II-IV 61% and 57% (P = 0.495); III-IV 23% and 21% (P = 0.608).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP948804.RAf7eYoSAJDs3xvF6Ld7AozMn6x7gI4YRTyXWhcO3OGlo130_provenance.
- NP948804.RAf7eYoSAJDs3xvF6Ld7AozMn6x7gI4YRTyXWhcO3OGlo130_assertion evidence source_evidence_literature NP948804.RAf7eYoSAJDs3xvF6Ld7AozMn6x7gI4YRTyXWhcO3OGlo130_provenance.
- NP948804.RAf7eYoSAJDs3xvF6Ld7AozMn6x7gI4YRTyXWhcO3OGlo130_assertion SIO_000772 17130788 NP948804.RAf7eYoSAJDs3xvF6Ld7AozMn6x7gI4YRTyXWhcO3OGlo130_provenance.
- NP948804.RAf7eYoSAJDs3xvF6Ld7AozMn6x7gI4YRTyXWhcO3OGlo130_assertion wasDerivedFrom befree-20150227 NP948804.RAf7eYoSAJDs3xvF6Ld7AozMn6x7gI4YRTyXWhcO3OGlo130_provenance.
- NP948804.RAf7eYoSAJDs3xvF6Ld7AozMn6x7gI4YRTyXWhcO3OGlo130_assertion wasGeneratedBy ECO_0000203 NP948804.RAf7eYoSAJDs3xvF6Ld7AozMn6x7gI4YRTyXWhcO3OGlo130_provenance.